Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Marijuana and MultiCell Technologies News: (OTC Pink: MJNA), (OTCQB: MCET)

MJNA
Medical Marijuana and MultiCell Technologies News: (OTC Pink: MJNA), (OTCQB: MCET)

New York (March 1st, 2013) - Medical Marijuana, Inc. (OTC Pink: MJNA) a leading cannabis and hemp industry innovator provided a comprehensive update to shareholders on the state of the medical cannabis and hemp industry. Many legislative actions have occurred, particularly since the November elections, which are providing significant positive momentum in our rapidly expanding markets.

Marijuana legalization initiatives have been in full swing. In November two US States, Colorado and Washington passed laws regarding full legalization of marijuana for recreational purposes. Since 1996, eighteen total states and Washington DC have approved marijuana for medical usage.

Nine other States have pending legislation to legalize medicinal marijuana including: Illinois, Iowa, Kansas, Kentucky, Maryland, New Hampshire, North Carolina, New York and Oklahoma.

Medical Marijuana Inc. operates in the medical marijuana and industrial hemp markets.

Get the latest news and reports on MJNA here:

http://www.wallstreetscoop.net/market-scan/?symbol=MJNA


MultiCell Technologies, Inc. (OTCQB:MCET) traded at 0.0038 in the last session, which is -0.0012 (-24.00%). The stock has a Range of 0.00 - 0.01. The stock has a 52 week low and high of 0.00 - 0.01 respectively. The stock has a market cap of 4.73M. The stock traded a volume of 158.28M. The stock has a 30 day average volume of 59.48M.

MultiCell Technologies, Inc. (MCET) recently gave a presentation on preclinical research results of Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma at the American Society for Cell Biology. This presentation was delivered by Simona Bot who is the M.D of the company.

MultiCell Technologies, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapeutic products by using its immune system modulation technologies.

Find out where MCET could be headed by getting the full trend analysis report here:

http://www.wallstreetscoop.net/market-scan/?symbol=MCET


About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today